Cargando…

Changes in miR-122 and Cholesterol Expression in Chronic Hepatitis C Patients after PegIFN-Alpha/Ribavirin Treatment

The hepatitis C virus (HCV) is known as a main etiological cause of chronic hepatitis. HCV infection disturbs cholesterol metabolism of the host, which is frequently observed in patients suffering from chronic hepatitis C (CHC). The course of viral infections remains under strict control of microRNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sidorkiewicz, Malgorzata, Grek-Kowalinska, Martyna, Piekarska, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350302/ https://www.ncbi.nlm.nih.gov/pubmed/32630479 http://dx.doi.org/10.3390/pathogens9060514

Ejemplares similares

The Correlation between miR-122 and Lipoprotein Lipase Expression in Chronic Hepatitis C Patients
por: Sidorkiewicz, Malgorzata, et al.
Publicado: (2018)

Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Grubczak, Kamil, et al.
Publicado: (2021)

Test of IL28B Polymorphisms in Chronic Hepatitis C Patients Treated with PegIFN and Ribavirin Depends on HCV Genotypes: Results from a Meta-Analysis
por: Jia, Zhifang, et al.
Publicado: (2012)

Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4
por: Rizk, Hanan H., et al.
Publicado: (2016)

Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study
por: Izumi, Namiki, et al.
Publicado: (2012)

Pre-Existing HCV Variants Resistant to DAAs and Their Sensitivity to PegIFN/RBV in Chinese HCV Genotype 1b Patients
por: Zhang, Yu, et al.
Publicado: (2016)

PEG-IFN Alpha but Not Ribavirin Alters NK Cell Phenotype and Function in Patients with Chronic Hepatitis C
por: Markova, Antoaneta A., et al.
Publicado: (2014)

Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs
por: Huang, Jing, et al.
Publicado: (2017)

CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV
por: Lin, Chia-Chen, et al.
Publicado: (2017)

Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial
por: Woo, Hyun Young, et al.
Publicado: (2022)

Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy
por: Sandoughdaran, Saleh, et al.
Publicado: (2015)

Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study
por: Atsukawa, Masanori, et al.
Publicado: (2013)

miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma
por: Shyu, Yu-Chiau, et al.
Publicado: (2016)

Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors
por: Israelow, Benjamin, et al.
Publicado: (2014)

The altered expression of α1 and β3 subunits of the gamma-aminobutyric acid A receptor is related to the hepatitis C virus infection
por: Sidorkiewicz, M., et al.
Publicado: (2011)

Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/Ribavirin therapy in chronic hepatitis C patients
por: Murata, Kazumoto, et al.
Publicado: (2013)

Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/Ribavirin
por: Bagaglio, Sabrina, et al.
Publicado: (2015)

Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24
por: Saadoun, David, et al.
Publicado: (2014)

Regulation of hepatic glutamine metabolism by miR-122
por: Sengupta, Dipanwita, et al.
Publicado: (2020)

Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNα2a shows earlier viral decline than peg-IFNα2b in combination therapy with ribavirin
por: Fujino, Tatsuya, et al.
Publicado: (2011)

Hepatic HMOX1 Expression Positively Correlates with Bach-1 and miR-122 in Patients with HCV Mono and HIV/HCV Coinfection
por: Jabłonowska, Elżbieta, et al.
Publicado: (2014)

Dual Role of miR-122 in Molecular Pathogenesis of Viral Hepatitis
por: Sendi, Hossein
Publicado: (2012)

miR-122-5p as a novel biomarker for alpha-fetoprotein-producing gastric cancer
por: Maruyama, Suguru, et al.
Publicado: (2018)

miR-155 and miR-122 Expression of Spermatozoa in Obese Subjects
por: López, Paulina, et al.
Publicado: (2018)

Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population
por: Jin, Young-Joo, et al.
Publicado: (2013)

Characterization of miR-122-independent propagation of HCV
por: Ono, Chikako, et al.
Publicado: (2017)

Viral Determinants of miR-122-Independent Hepatitis C Virus Replication
por: Hopcraft, Sharon E., et al.
Publicado: (2015)

Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country
por: Hlaing, Naomi Khaing Than, et al.
Publicado: (2016)

Peg-interfon alpha-2a and low-dose ribavirin for treatment of hepatitis C virus infection in patients with sickle-cell anemia in Saudi Arabia
por: Agha, Adnan, et al.
Publicado: (2013)

Leishmania donovani Targets Dicer1 to Downregulate miR-122, Lower Serum Cholesterol, and Facilitate Murine Liver Infection
por: Ghosh, June, et al.
Publicado: (2013)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
por: Amr, Khalda S., et al.
Publicado: (2017)

Role of miR-122 and lipid metabolism in HCV infection
por: Fukuhara, Takasuke, et al.
Publicado: (2012)

The effects of hepatitis C virus core protein on the expression of miR-122 in vitro
por: Li, Sujuan, et al.
Publicado: (2013)

Enhancement of hepatitis C viral RNA abundance by precursor miR-122 molecules
por: Cox, Erica Machlin, et al.
Publicado: (2013)

MicroRNAs and hepatitis C virus: Toward the end of miR-122 supremacy
por: Hoffmann, Thomas Walter, et al.
Publicado: (2012)

MicroRNA-122 Regulation of HCV Infections: Insights from Studies of miR-122-Independent Replication
por: Panigrahi, Mamata, et al.
Publicado: (2022)

Suppression of ribosomal protein synthesis and protein translation factors by Peg-interferon alpha/ribavirin in HCV patients blood mononuclear cells (PBMC)
por: Gupta, Rahul, et al.
Publicado: (2012)

Various miRNAs compensate the role of miR-122 on HCV replication
por: Ono, Chikako, et al.
Publicado: (2020)

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial
por: Colombatto, P, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rlefn8hk72tkpuh59jsgsvb5jn